
    
      Study duration is expected to be completed in a period of 3 year. The study will enroll 40
      patients with VP and 20 healthy subjects.

      This neuroimaging study includes the 18F-FP-(+)-DTBZ PET, MRI structure images, diffusion
      tensor imaging, susceptibility weighted imaging, resting state and gait-related imagery task
      functional MRI. Each evaluable subject involved in this study must fulfill all the inclusion
      and exclusion criteria according the subject group, each subject will have 3 visits in this
      study. Safety measurement for 18F-FP-(+)-DTBZ will be evaluated by medical history, vital
      signs, physical examinations, laboratory examinations and collecting of adverse events.
    
  